For: | Qiao JG, Zhang YQ, Yin YC, Tan Z. Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2. World J Gastroenterol 2004; 10(18): 2759-2761 [PMID: 15309737 DOI: 10.3748/wjg.v10.i18.2759] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i18/2759.htm |
Number | Citing Articles |
1 |
Pisanu Buphamalai, Tomislav Kokotovic, Vanja Nagy, Jörg Menche. Network analysis reveals rare disease signatures across multiple levels of biological organization. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-26674-1
|
2 |
Malte Buchholz, Thomas M Gress. Molecular changes in pancreatic cancer. Expert Review of Anticancer Therapy 2009; 9(10): 1487 doi: 10.1586/era.09.107
|
3 |
Felix Rückert, Nicole Samm, Anne-Kathrin Lehner, Hans-Detlev Saeger, Robert Grützmann, Christian Pilarsky. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-379
|
4 |
Shikhar Mehrotra, Carolyn D. Britten, Steve Chin, Elizabeth Garrett-Mayer, Colleen A. Cloud, Mingli Li, Gina Scurti, Mohamed L. Salem, Michelle H. Nelson, Melanie B. Thomas, Chrystal M. Paulos, Andres M. Salazar, Michael I. Nishimura, Mark P. Rubinstein, Zihai Li, David J. Cole. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. Journal of Hematology & Oncology 2017; 10(1) doi: 10.1186/s13045-017-0459-2
|
5 |
Ryan Stevenson, Martin Goodman, Muhammad Wasif Saif. Cancer Immunology. 2015; : 237 doi: 10.1007/978-3-662-46410-6_12
|
6 |
Yian Chen, Bin Zheng, David H. Robbins, David N. Lewin, Kaidi Mikhitarian, Amanda Graham, Laurrie Rumpp, Tammy Glenn, William E. Gillanders, David J. Cole, Xinghua Lu, Brenda J. Hoffman, Michael Mitas. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. International Journal of Cancer 2007; 120(7): 1511 doi: 10.1002/ijc.22487
|
7 |
Young-Soon Na, Soo-Jin Yang, Seung-Mi Kim, Kyung-Ah Jung, Jai-Hee Moon, Jae-Sik Shin, Dok Hyun Yoon, Yong Sang Hong, Min-Hee Ryu, Jae-Lyun Lee, Jung Shin Lee, Tae Won Kim, Guenter Schneider. YM155 Induces EGFR Suppression in Pancreatic Cancer Cells. PLoS ONE 2012; 7(6): e38625 doi: 10.1371/journal.pone.0038625
|
8 |
Hannes Borchardt, Alexander Ewe, Markus Morawski, Ulrike Weirauch, Achim Aigner. miR24–3p activity after delivery into pancreatic carcinoma cell lines exerts profound tumor-inhibitory effects through distinct pathways of apoptosis and autophagy induction. Cancer Letters 2021; 503: 174 doi: 10.1016/j.canlet.2021.01.018
|
9 |
Fengzhi Li, Michael G. Brattain. Role of the SurvivinGene in Pathophysiology. The American Journal of Pathology 2006; 169(1): 1 doi: 10.2353/ajpath.2006.060121
|
10 |
Cristiana Pistol Tanase, Monica Neagu, Radu Albulescu, Mihail Eugen Hinescu. . Advances in Clinical Chemistry 2010; 51: 145 doi: 10.1016/S0065-2423(10)51006-0
|
11 |
Jaya Nigam, Abhijit Chandra, Hasan Raza Kazmi, Devendra Parmar, Devendra Singh, Vishal Gupta. Prognostic significance of survivin in resected gallbladder cancer. Journal of Surgical Research 2015; 194(1): 57 doi: 10.1016/j.jss.2014.07.054
|
12 |
Said Abu-Alkhair Mohamed, Yasser Mohamed Eldowik. Expression of matrix metalloproteinase-2 and survivin in pancreatic carcinoma. Al-Azhar Assiut Medical Journal 2022; 20(3): 280 doi: 10.4103/azmj.azmj_106_21
|
13 |
Michaela Retzer‐Lidl, Roland M. Schmid, Günter Schneider. Inhibition of CDK4 impairs proliferation of pancreatic cancer cells and sensitizes towards TRAIL‐induced apoptosis via downregulation of survivin. International Journal of Cancer 2007; 121(1): 66 doi: 10.1002/ijc.22619
|
14 |
G. Garcea, C.P. Neal, C.J. Pattenden, W.P. Steward, D.P. Berry. Molecular prognostic markers in pancreatic cancer: A systematic review. European Journal of Cancer 2005; 41(15): 2213 doi: 10.1016/j.ejca.2005.04.044
|
15 |
Kuichun Zhu, Hong Qin, Soung-Chul Cha, Sattva S. Neelapu, Willem Overwijk, Gregory A. Lizee, James L. Abbruzzese, Patrick Hwu, Laszlo Radvanyi, Larry W. Kwak, David Z. Chang. Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models. Vaccine 2007; 25(46): 7955 doi: 10.1016/j.vaccine.2007.08.050
|
16 |
Lindzy F Dodson, William G Hawkins, Peter Goedegebuure. Potential Targets for Pancreatic Cancer Immunotherapeutics. Immunotherapy 2011; 3(4): 517 doi: 10.2217/imt.11.10
|
17 |
Praveen Bhoopathi, Bridget A. Quinn, Qin Gui, Xue-Ning Shen, Steven R. Grossman, Swadesh K. Das, Devanand Sarkar, Paul B. Fisher, Luni Emdad. Pancreatic Cancer–Specific Cell Death Induced In Vivo by Cytoplasmic-Delivered Polyinosine–Polycytidylic Acid. Cancer Research 2014; 74(21): 6224 doi: 10.1158/0008-5472.CAN-14-0819
|
18 |
Alex J. Félix, Carlos J. Ciudad, Véronique Noé. Functional pharmacogenomics and toxicity of PolyPurine Reverse Hoogsteen hairpins directed against survivin in human cells. Biochemical Pharmacology 2018; 155: 8 doi: 10.1016/j.bcp.2018.06.020
|
19 |
Zhongqiu Wang, Mingmin Tong, Xiao Chen, Shouyou Hu, Zhijian Yang, Yu Zhang, Hao Zhou, Yuefei Wu, Xiaoshuang Li, Donghui Li. Survivin-targeted nanoparticles for pancreatic tumor imaging in mouse model. Nanomedicine: Nanotechnology, Biology and Medicine 2016; 12(6): 1651 doi: 10.1016/j.nano.2016.02.008
|
20 |
Rainer Hamacher, Roland M Schmid, Dieter Saur, Günter Schneider. Apoptotic pathways in pancreatic ductal adenocarcinoma. Molecular Cancer 2008; 7(1) doi: 10.1186/1476-4598-7-64
|
21 |
Klaus L Prenzel, Ute Warnecke-Eberz, Jan Brabender, Stephan E Baldus, Elfriede Bollschweiler, Christian A Gutschow, Uta Drebber, Arnulf H Hoelscher, Paul M Schneider. Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater. World Journal of Gastroenterology 2006; 12(3): 437-442 doi: 10.3748/wjg.v12.i3.437
|